Sequential Treatment with FLAG-IDA Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapse/Refractory or Adverse-Risk Leukemia
Patients with relapse/refractory or adverse-risk leukemia have dismal prognosis with current therapeutic approaches. Salvage chemotherapy followed by allogeneic hematopoietic stem-cell transplantation (HSCT) is advisable but not always attainable due to disease resistance and the toxicity associated with current salvage approaches.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Ofir Wolach, Liat Shargian-Alon, Pia Raanani, Moshe Yeshurun Source Type: research
More News: Chemotherapy | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Toxicology | Transplants